ANI Pharmaceuticals develops, makes, and sells prescription medicines, including rare disease, brand name, and generic drugs. It last closed at $68.55 on Nov 20, down 0.84% on the day. The next earnings report for ANIP is expected around Mon, Jan 11, 2027, after the close. For the quarter ended Sep 2026, ANIP reported EPS of $1.51 on revenue of $290.8M, with revenue up 27.6% from a year ago. Over its last 8 reports the stock moved an average of 2.3% the session after earnings. Over the last 12 months ANIP insiders bought $0 of stock on the open market and sold $14.0M, according to SEC Form 4 filings.
AI Auto Pilots
Is ANIP in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold ANIP.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on ANIPStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
ANIP · as of the Nov 20 close · updated each morning
Downtrend
The stock is 3% below its 20 day and 5% below its 50 day average. It is 12% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 41). The nearest support is the Pivot S1 at $67.82, and the nearest resistance the Pivot at $69.01.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityHigh, 3.3%/day
Key levels
$87.7652 week high+28.0%
$76.74200 day average+11.9%
$74.90100 day average+9.3%
$72.2450 day average+5.4%
$72.24Swing high (Nov 11)+5.4%
$70.7520 day average+3.2%
$69.74Pivot R1+1.7%
$69.01Pivot+0.7%
$68.55Last close
$67.82Pivot S1−1.1%
$67.1452 week low−2.1%
$67.14Swing low (Nov 6)−2.1%
Indicators
RSI (14)
41.30
Middle of its range
Neutral
MACD
-0.71
Below its signal line
Bearish
Stochastic
29.1
Middle of its range
Neutral
ADX (14)
9.2
No clear trend
Williams %R
-84.0
Oversold below −80, overbought above −20
Oversold
CCI (20)
-124.0
Oversold below −100, overbought above 100
Oversold
Rate of change
+1.7%
Change over 10 sessions
Bullish
ATR (14)
$2.28
Typical daily range, 3.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Pullback inside a longer uptrend
Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityNormal, 7.2%/day
Key levels
$87.7652 week high+28.0%
$76.74200 day average+11.9%
$74.90100 day average+9.3%
$72.2450 day average+5.4%
$72.24Swing high (Nov 11)+5.4%
$70.7520 day average+3.2%
$69.74Pivot R1+1.7%
$69.01Pivot+0.7%
$68.55Last close
$67.82Pivot S1−1.1%
$67.1452 week low−2.1%
$67.14Swing low (Nov 6)−2.1%
Indicators
RSI (14)
40.45
Middle of its range
Neutral
MACD
-2.41
Below its signal line
Bearish
Stochastic
16.1
Near the bottom of its range
Oversold
ADX (14)
15.5
No clear trend
Williams %R
-88.5
Oversold below −80, overbought above −20
Oversold
CCI (20)
-105.7
Oversold below −100, overbought above 100
Oversold
Rate of change
−2.3%
Change over 10 sessions
Bearish
ATR (14)
$4.92
Typical daily range, 7.2% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
What happened before, for ANIP
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how ANIP did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow ANIP usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for ANIPHow many large options trades hit ANIP, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in ANIP in the last 90 days.
From SEC Form 4 filings by ANIP's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ANIP is in one of them and how their past ANIP trades turned out.
ANI Pharmaceuticals is a biopharmaceutical company based in Princeton, New Jersey. It develops, manufactures, and sells prescription medicines in three areas: rare disease treatments, brand name products, and generic drugs. Its rare disease products include Purified Cortrophin Gel and the ILUVIEN and YUTIQ eye implants, which treat conditions such as diabetic macular edema and uveitis. The company makes its products at its own plants in Minnesota and New Jersey and sells them to patients, physicians, and specialty pharmacies.